Cargando…
Rising Health Care Costs and Life-Cycle Management in the Pharmaceutical Market
Aaron Kesselheim discusses Natalie Vernaz and colleagues' paper on the effects on health care costs of “evergreening” strategies pursued by drug manufacturers. Please see later in the article for the Editors' Summary
Autor principal: | Kesselheim, Aaron S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681333/ https://www.ncbi.nlm.nih.gov/pubmed/23785261 http://dx.doi.org/10.1371/journal.pmed.1001461 |
Ejemplares similares
-
Same Song, Different Audience: Pharmaceutical Promotion Targeting Non-Physician Health Care Providers
por: Yeh, James S., et al.
Publicado: (2013) -
Regulatory Solutions to the Problem of High Generic Drug Costs
por: Luo, Jing, et al.
Publicado: (2015) -
How Basic Scientists Help the Pharmaceutical Industry Market Drugs
por: Fugh-Berman, Adriane
Publicado: (2013) -
Strategies and Practices in Off-Label Marketing of Pharmaceuticals: A
Retrospective Analysis of Whistleblower Complaints
por: Kesselheim, Aaron S., et al.
Publicado: (2011) -
Drug Product Life-Cycle Management as Anticompetitive Behavior: The Case of Memantine
por: Capati, Vincent C., et al.
Publicado: (2016)